---All---
  • ---All---
  • Accession
  • Catalog #

Phospho-ERBB3- Y1289 AntibodyPeptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP3708a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP3708a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Phospho-ERBB3- Y1289 Antibody - Product info

ApplicationDB, WB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP21860
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW148098 Da

Phospho-ERBB3- Y1289 Antibody - Additional info

Gene ID 2065
Other Names
ERBB3; HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; Tyrosine kinase-type cell surface receptor HER3
Target/Specificity
This Phospho-ERBB3-Y1289 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 1275~1304 amino acids surrounding Y1289 of human ERBB3.
Dilution
DB~~1:500
WB~~1:1000
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Phospho-ERBB3- Y1289 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

Phospho-ERBB3- Y1289 Antibody - Protein Information

Name ERBB3
Synonyms HER3
Function
Binds and is activated by neuregulins and NTAK.
Cellular Location
Isoform 1: Cell membrane; Single-pass type I membrane protein
Tissue Location
Epithelial tissues and brain.

Phospho-ERBB3- Y1289 Antibody - Related products

AP3708a: Phospho-ERBB3- Y1289 Antibody

AP7630a: ERBB3 Antibody (N-term)

RI11825: ERBB3 predesign siRNA

DC01074: Human ERBB3 cDNA Clone

BP3708a: Phospho-ERBB3-Y1289 Antibody Blocking Peptide

BP7630a: ErbB3 Antibody (N-term) Blocking Peptide

AO1202a: ERBB3 Antibody

AO1202b: ERBB3 Antibody

AO1295a: ERBB3 Antibody

AJ1341a: HER3 (ErbB3) Antibody (C-term)

AJ1341b: HER3/ErbB3 Antibody Phospho (pY1289)

AF1376a: ERBB3 / HER3 Antibody

AE1015a: Her3 (ErbB3) Antibody (Y1328)

AE1015b: Phospho-Her3 (ErbB3)-Y1328 Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form.

REFERENCES

Huang, X., et al. Cancer Res. 70(3):1204-1214(2010) Pierce, B.L., et al. Hum. Hered. 69(3):193-201(2010) Li, D., et al. World J. Biol. Psychiatry 10 (4 PT 2), 595-598 (2009) Carr, E.J., et al. BMC Med. Genet. 10, 121 (2009) Zhang, Y., et al. BMC Cell Biol. 10, 78 (2009)